Literature DB >> 19541828

Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.

Ye Li1, David Buckley, Shuang Wang, Curtis D Klaassen, Xiao-bo Zhong.   

Abstract

Transcription of UDP-glucuronosyltransferase (UGT) 1A1 is regulated by the transcription factors, constitutive androstane receptor (CAR), pregnane X receptor (PXR), glucocorticoid receptor (GR), hepatocyte nuclear factor (HNF) 1 alpha, and HNF4 alpha. The purpose of this study was to determine whether the genetic polymorphisms in the RNA polymerase II core promoter and the upstream phenobarbital-responsive element module (PBREM) of the UGT1A1 promoter have combined effects on UGT1A1 transcription mediated by the transcription factors. A polymorphism of A(TA)(5-8)TAA in the UGT1A1 TATA box and a single nucleotide polymorphism of -3279T>G in PBREM were genotyped in 98 human liver samples. Relative mRNA levels of CAR, PXR, GR, HNF1 alpha, HNF4 alpha, and UGT1A1 were quantified by a multiplex branched DNA technique. Correlations of mRNA levels between UGT1A1 and the transcription factors were established in liver samples with different combined genetic polymorphisms. Correlation of mRNA levels between UGT1A1 and CAR, PXR, or GR, but not HNF1 alpha or HNF4 alpha, was abolished in the samples with the combined genotype of TA7/7 plus -3279G/G, which was also associated with significantly lower UGT1A1 mRNA levels compared with other combined genotypes. Correlations of mRNA levels between UGT1A1 and CAR or PXR were reduced but not abolished in the samples with the combined genotype of TA6/7 plus -3279 G/G, which showed significantly lower UGT1A1 mRNA levels compared with the combined genotype of TA6/7 plus -3279T/G and other genotypes containing TA6/6. In conclusion, the combined genotypes containing A(TA)(7)TAA and -3279G decrease UGT1A transcription mediated by CAR, PXR, or GR but not by HNF1 alpha or HNF4 alpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541828      PMCID: PMC2729330          DOI: 10.1124/dmd.109.027409

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  31 in total

Review 1.  The RNA polymerase II core promoter: a key component in the regulation of gene expression.

Authors:  Jennifer E F Butler; James T Kadonaga
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

2.  Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Authors:  Federico Innocenti; Carrie Grimsley; Soma Das; Jacqueline Ramírez; Cheng Cheng; Hala Kuttab-Boulos; Mark J Ratain; Anna Di Rienzo
Journal:  Pharmacogenetics       Date:  2002-12

3.  UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.

Authors:  L Iyer; S Das; L Janisch; M Wen; J Ramírez; T Karrison; G F Fleming; E E Vokes; R L Schilsky; M J Ratain
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

4.  Long-range chromatin regulatory interactions in vivo.

Authors:  David Carter; Lyubomira Chakalova; Cameron S Osborne; Yan-feng Dai; Peter Fraser
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

5.  The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR.

Authors:  J Sugatani; H Kojima; A Ueda; S Kakizaki; K Yoshinari; Q H Gong; I S Owens; M Negishi; T Sueyoshi
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

6.  The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics.

Authors:  Junko Sugatani; Kasumi Yamakawa; Eri Tonda; Shinichi Nishitani; Kouichi Yoshinari; Masakuni Degawa; Ikuro Abe; Hiroshi Noguchi; Masao Miwa
Journal:  Biochem Pharmacol       Date:  2004-03-01       Impact factor: 5.858

7.  Variations in the UDP-glucuronosyltransferase 1A1 gene for the development of unconjugated hyperbilirubinemia in Taiwanese.

Authors:  Yang-Yang Huang; May-Jen Huang; Sieng-Sien Yang; Hsiu-Chen Teng; Ching-Shan Huang
Journal:  Pharmacogenomics       Date:  2008-09       Impact factor: 2.533

8.  Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

Authors:  Federico Innocenti; Samir D Undevia; Lalitha Iyer; Pei Xian Chen; Soma Das; Masha Kocherginsky; Theodore Karrison; Linda Janisch; Jacqueline Ramírez; Charles M Rudin; Everett E Vokes; Mark J Ratain
Journal:  J Clin Oncol       Date:  2004-03-08       Impact factor: 44.544

9.  Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

Authors:  S Aono; Y Adachi; E Uyama; Y Yamada; H Keino; T Nanno; O Koiwai; H Sato
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

10.  UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.

Authors:  E Marcuello; A Altés; A Menoyo; E Del Rio; M Gómez-Pardo; M Baiget
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

View more
  8 in total

1.  Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors:  Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal:  Eur J Clin Pharmacol       Date:  2016-10-05       Impact factor: 2.953

Review 2.  Gene polymorphisms and their role in epilepsy treatment and prognosis.

Authors:  Ortrud K Steinlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-16       Impact factor: 3.000

3.  [A case of Gilbert syndrome caused by UGT1A1 gene compound heterozygous mutations].

Authors:  Weijie Ou; Su Lin; Yilong Wu; Yueyong Zhu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

4.  Group Theory of Syntactical Freedom in DNA Transcription and Genome Decoding.

Authors:  Michel Planat; Marcelo M Amaral; Fang Fang; David Chester; Raymond Aschheim; Klee Irwin
Journal:  Curr Issues Mol Biol       Date:  2022-03-22       Impact factor: 2.976

5.  Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.

Authors:  Otito F Iwuchukwu; QiPing Feng; Wei-Qi Wei; Lan Jiang; Min Jiang; Hua Xu; Joshua C Denny; Russell A Wilke; Ronald M Krauss; Dan M Roden; C Michael Stein
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

6.  Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.

Authors:  Wanqing Liu; Jacqueline Ramírez; Eric R Gamazon; Snezana Mirkov; Peixian Chen; Kehua Wu; Chang Sun; Nancy J Cox; Edwin Cook; Soma Das; Mark J Ratain
Journal:  Hum Mol Genet       Date:  2014-05-30       Impact factor: 6.150

7.  Regulation of bilirubin clearance by ligand-activated transcription factors of the endo- and xenobiotic metabolism system.

Authors:  Karl Walter Bock
Journal:  Front Pharmacol       Date:  2011-12-26       Impact factor: 5.810

8.  UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.

Authors:  Kuerbanjiang Abuduxikuer; Ling-Juan Fang; Li-Ting Li; Jing-Yu Gong; Jian-She Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.